Canakinumab, a fully-human mAb against IL-1beta for the potential treatment of inflammatory disorders. (Q52850198)
Jump to navigation
Jump to search
scientific article published in February 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Canakinumab, a fully-human mAb against IL-1beta for the potential treatment of inflammatory disorders. |
scientific article published in February 2009 |
Statements
Canakinumab, a fully-human mAb against IL-1beta for the potential treatment of inflammatory disorders (English)